Precigen, Inc. (PGEN)
7.815
+0.22
(+2.83%)
USD |
NASDAQ |
Oct 09, 16:00
7.81
0.00 (0.00%)
After-Hours: 20:00
Precigen Cash from Operations (Quarterly) : -17.81M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.81M |
| March 31, 2026 | -43.83M |
| December 31, 2025 | -23.46M |
| September 30, 2025 | -29.07M |
| June 30, 2025 | -18.98M |
| March 31, 2025 | -16.32M |
| December 31, 2024 | -8.243M |
| September 30, 2024 | -22.73M |
| June 30, 2024 | -23.11M |
| March 31, 2024 | -14.09M |
| December 31, 2023 | -15.77M |
| September 30, 2023 | -17.01M |
| June 30, 2023 | -15.77M |
| March 31, 2023 | -18.39M |
| December 31, 2022 | -15.40M |
| September 30, 2022 | -23.81M |
| June 30, 2022 | -7.053M |
| March 31, 2022 | -18.78M |
| December 31, 2021 | -14.59M |
| September 30, 2021 | -17.02M |
| June 30, 2021 | -7.776M |
| March 31, 2021 | -16.38M |
| December 31, 2020 | -16.47M |
| September 30, 2020 | -19.00M |
| June 30, 2020 | -13.80M |
| Date | Value |
|---|---|
| March 31, 2020 | -27.74M |
| December 31, 2019 | -32.14M |
| September 30, 2019 | -27.15M |
| June 30, 2019 | -33.40M |
| March 31, 2019 | -43.23M |
| December 31, 2018 | -37.36M |
| September 30, 2018 | -28.82M |
| June 30, 2018 | -28.17M |
| March 31, 2018 | -29.89M |
| December 31, 2017 | -33.88M |
| September 30, 2017 | -22.01M |
| June 30, 2017 | -23.56M |
| March 31, 2017 | -24.69M |
| December 31, 2016 | -24.20M |
| September 30, 2016 | -8.744M |
| June 30, 2016 | -12.44M |
| March 31, 2016 | -3.609M |
| December 31, 2015 | 12.33M |
| September 30, 2015 | 52.90M |
| June 30, 2015 | -16.52M |
| March 31, 2015 | -13.04M |
| December 31, 2014 | -9.05M |
| September 30, 2014 | -6.637M |
| June 30, 2014 | -13.65M |
| March 31, 2014 | 9.479M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Repligen Corp. | 32.77M |
| AC Immune SA | -- |
| Amgen, Inc. | 4.002B |
| Geron Corp. | -15.83M |
| Neurocrine Biosciences, Inc. | 78.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 26.69M |
| Cash from Financing (Quarterly) | -0.033M |
| Free Cash Flow | -115.22M |
| Free Cash Flow Per Share (Quarterly) | -0.044 |
| Free Cash Flow to Equity (Quarterly) | -18.30M |
| Free Cash Flow to Firm (Quarterly) | -15.25M |
| Free Cash Flow Yield | -4.13% |